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Abstract
Background: Carbenoxolone, as an antiulcer medicine, has some pharmacological properties
such as: the inhibition of gap junctional (GJ) intercellular communication. In vitro studies have
shown, carbenoxolone to abolish the generation of full or partial ectopic spike generation, by 4-
aminopyridine, as well as spontaneous epileptiform activity in CA3 or CA1 regions of the rat
hippocampal slices via closing GJ channels. Thus, we considered the possible anticonvulsant effects
of carbenoxolone in animal seizure models.
Results: ED50 values of diazepam and carbenoxolone in the pentylenetetrazole model were 1.13
mg/kg and 283.3 mg/kg, respectively. In this model, carbenoxolone in doses of 200 and 300 mg/kg
prolonged the onset time of seizure and decreased the duration of seizures. In the maximal
electroshock model, carbenoxolone in a dose of 400 mg/kg decreased the duration of seizure
producing protection against seizure but failing to protect against mortality in comparison with
diazepam. In the potentiation of pentobarbitone sleep test, carbenoxolone significantly increased
sleeping time and decreased latency in doses of 100, 200 and 300 mg/kg in mice dose dependently.
In the traction test, carbenoxolone (400 mg/kg) showed muscle relaxant activity and in the
accelerated rotarod test, carbenoxolone in doses of 200 and 300 mg/kg showed a decline in motor
coordination.
Conclusion: It can be concluded that carbenoxolone possesses anticonvulsant, muscle relaxant
and hypnotic effects, which could contribute to the control of petit mal and grand mal seizures.
Background
Carbenoxolone, the succinyl ester of glycyrrhetinic acid
[1], is now used in clinical treatment of ulcer diseases [2].
It has some pharmacological properties such as: the inhi-
bition of 11β-hydroxy steroid dehydrogenase (11β-HSD)
[1], and inhibition of gap junctional intercellular commu-
nication [3]. Electrotonic synaptic communication be-
tween neurons via gap junctions (GJs) is increasingly
recognized as an important synchronizing mechanism in
the brain. The pathogenesis of abnormal neuronal syn-
chrony underlying seizures, formerly thought to be based
mainly on the chemical synaptic transmission, now in-
cludes a role of gap junctional communication. This con-
cept has been strengthened by evidence from several in
vitro models, in which pharmacological manipulations of
gap junctional communication predictably affect the gen-
eration of seizures: blockers diminishing seizure, and en-
hancers increasing the seizures [4]. GJ channels can
contribute to the prolongation of epileptiform discharges
[5].
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In in vitro studies, carbenoxolone abolished the genera-
tion of full or partial ectopic spike generation, by 4-AP, in
the CA3  region of rat hippocampal slices [6]. Also
carbenoxolone depresses spontaneous epileptiform activ-
ity in the CA1  region of rat hippocampal slices [7].
Carbenoxolone appears to cross the blood brain barrier
about one hour after an intraperitoneal injection in rats as
there was the inhibition of 11-β-hydroxysteroid dehydro-
genase in multiple brain regions [1]. It and/or its congener
glycyrrehetinic acid may also enter the eyes of humans. In-
gestion of licorice has been reported to cause transient vis-
ual loss [8], a possible consequence of retinal gap junction
blockade.
Thus, we considered the possible anticonvulsant effect of
carbenoxolone in animal seizure models.
Results
In pentylenetetrazole (PTZ) model, ED50 values of di-
azepam and carbenoxolone were 1.13 mg/kg (%95 CL :
0.89, 1.44) and 283.3 mg/kg (%95 CL : 144.27, 556.29),
respectively.
In PTZ model, carbenoxolone increased the latency of sei-
zures and decreased the duration of seizures, dose de-
pendently (Table 1).
In maximal electroshock (MES) model, carbenoxolone
(400 mg/kg) decreased the duration of tonic seizures. This
effect was not statistically significant in the lower doses of
carbenoxolone. This agent could not completely protect
the mice against mortality in a dose of 400 mg/kg (Table
2).
In the potentiation of pentobarbitone sleep test,
carbenoxolone significantly increased the sleeping time in
mice at doses of 100, 200 and 300 mg/kg compared to
controls dose dependently (Table 3). Also, carbenoxolone
in doses of 100, 200 and 300 mg/kg decreased the latency
compared to controls dose dependently and this effect
was statistically significant (Table 3).
In the traction test, carbenoxolone did not induce a mus-
cle relaxant activity significantly up to a dose of 400 mg/
Table 1: Anticonvulsant effect of carbenoxolone in the pentylenetetrazole-induced convulsion in mice
Treatment Dose Onset of seizure(sec) Duration of clonic seizure (sec) Seizure protection (%) Mortality protection (%)
Normal saline 10 ml/kg 50.83 ± 8.14 25.83 ± 4.47 0 0
Diazepam 0.1 mg/kg 45.58 ± 2.61 9.68 ± 0.49*** 0 0
0.5 mg/kg 121.73 ± 4.91 7.9 ± 0.52*** 0 100
1 mg/kg 439.61 ± 60.80*** 4.7 ± 1.67*** 42.8 100
1.5 mg/kg 587.18 ± 12.86*** 0.71 ± 0.71*** 85.7 100
3 mg/kg 600*** 0*** 100 100
Carbenoxolone 100 mg/kg 213.14 ± 66.59 6.35 ± 1.55*** 14.3 57.14
200 mg/kg 388.9 ± 71.74* 3.28 ± 1.06*** 28.6 57.14
300 mg/kg 464.9 ± 66.6** 3 ± 1.91*** 57.14 28.6
Carbenoxolone and diazepam (i.p.) were injected 60 and 30 minutes respectively, before the administration of pentylenetetrazole (i.p. 90 mg/kg). 
Values are the mean ± SEM for 7 mice. *P < 0.05, **P < 0.01, ***P < 0.001, Compared to control, Tukey-Kramer Test.
Table 2: Anticonvulsant effect of carbenoxolone against seizure induced by maximal electroshock in mice
Treatment Dose Duration of tonic seizure (sec) Seizure protection (%) Mortality protection (%)
Normal saline 10 ml/kg 17.57 ± 1.72 0 14.28
Diazepam 0.25 mg/kg 11.8 ± 0.48** 0 100
0.5 mg/kg 8.63 ± 0.21*** 0 100
3 mg/kg 6.06 ± 1.27*** 14.3 100
Carbenoxolone 100 mg/kg 12.11 ± 2.28 14.3 85.7
200 mg/kg 12.10 ± 2.04 14.3 87.7
300 mg/kg 11.85 ± 1.61 14.3 60
400 mg/kg 9.16 ± 1.71* 28.6 14.28
Carbenoxolone and diazepam (i.p.) were injected 60 and 30 minutes respectively, before the induction of maximal electroshock seizures, respec-
tively. Values are the mean ± SEM for 7 mice. *P < 0.05, ***P < 0.001, Compared to control, Tukey-Kramer Test.BMC Pharmacology 2003, 3 http://www.biomedcentral.com/1471-2210/3/3
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kg. Carbenoxolone (400 mg/kg) showed muscle relaxant
activity compared to normal saline, and this effect was
more than diazepam in a dose of 0.25 mg/kg (Table 4).
In accelerod performances, carbenoxolone in the first trial
in doses of 100, 200 and 300 mg/kg, showed a decline in
motor function relative to normal saline (10 ml/kg) (Ta-
ble 5). The second trial, carbenoxolone in doses of 200
and 300 mg/kg decreased the riding time on rotarod com-
pare to normal saline (Table 5).
Discussion
Present results indicate that carbenoxolone has anticon-
vulsant activities in PTZ and MES models.
Agents affecting the PTZ model can inhibit petit mal sei-
zure [9]. Thus, carbenoxolone may have activity on this
kind of seizure. Carbenoxolone also showed activity
against MES. This implies that carbenoxolone may have
efficacy in grand mal seizure [9].
Less is known about the effects of carbenoxolone on GJs,
although it has been proposed that glycyrrhetinic acid, to
which carbenoxolone is related, binds directly to connex-
in molecules causing a conformational change leading to
a closure of the junction [7]. Modeling studies indicate
that neuronal synchronization can be mediated by low
densities of GJs either between dendrites, as long as these
dendrites are excitable [10], or between the axons of py-
Table 3: Potentiation of the pentobarbital sleep with carbenoxolone in mice
Treatment Dose Latency (min) Duration (min)
Normal saline 10 ml/kg 7.28 ± 2.09 28.01 ± 1.88
Diazepam 1 mg/kg 4.67 ± 0.43** 49.16 ± 4.67***
Carbenoxolone 100 mg/kg 4.33 ± 0.25** 65.55 ± 5.06***
200 mg/kg 4.24 ± 0.31** 75.10 ± 7.34***
300 mg/kg 3.63 ± 0.38*** 93.32 ± 16.49***
Carbenoxolone and diazepam (i.p.) were injected 60 and 30 minutes respectively, before pentobarbital (30 mg/kg) respectively. Mean latency and 
duration of sleep in minutes ± SEM from 10 mice in each group. **P < 0.01, ***P < 0.001, compared to control, Tukey-Kramer test.
Table 4: Effect of Carbenoxolone on muscle relaxant activity by traction test
Treatment Dose % failure
Normal saline 10 ml/kg 0
Diazepam 0.125 mg/kg 0
0.25 mg/kg 50*
0.5 mg/kg 100***
Carbenoxolone 200 mg/kg 20
300 mg/kg 40
400 mg/kg 60**
Carbenoxolone and diazepam (i.p.) were injected 60 and 30 minutes respectively, before the test. Values are the mean ± SEM for 10 mice, *P < 
0.05, **P < 0.01, ***P < 0.001, Compared to control, Fisher's exact test (two sided)
Table 5: Effect of carbenoxolone on muscle relaxant activity by accelerod test
Treatment Dose First trial (sec) Second trial (sec)
Normal saline 10 ml/kg 300 300
Diazepam 1 mg/kg 7.6 ± 10.95** 24.96 ± 11.74**
Carbenoxolone 100 mg/kg 18.87 ± 6.57** 221.21 ± 37.55
200 mg/kg 9.78 ± 1.60** 71.44 ± 38.25**
300 mg/kg 3.55 ± 1.19** 33.46 ± 26.64**
Carbenoxolone and diazepam (i.p.) were injected 60 and 30 minutes respectively, before the first trial. Values are the mean ± SEM for 10 mice. **P 
< 0.01, Compared to control, Dunnett's testBMC Pharmacology 2003, 3 http://www.biomedcentral.com/1471-2210/3/3
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ramidal cells [11]. Furthermore, the electrotonic coupling
could be promoted during epileptogenesis [12,13].
Optical imaging of neural activity evoked by electrical
stimulation in the cultured rat suprachiasmatic nucleus
(SCN) revealed that the spread of depolarization was in-
hibited by gap junction blockers (halothane, octanol) but
not by a blocker of voltage-depended Na+ channels. De-
polarization propagation was also inhibited by musci-
mol, a GABAA  receptor agonist, in a dose dependent
manner, and inhibition was reversed by bicuculline, a
GABAA receptor antagonist. This indicated that the propa-
gation of depolarization between SCN cells was inhibited
by GABAA receptor activation. There were two possible ex-
planations for this result. First, GABA might affect the per-
meability of gap junction channels. Secondly, muscimol
might increase the chloride conductance independent of
gap junctions, and might cause a decrease in the spread of
depolarization. Furthermore, muscimol inhibited dye-
transfer between neurons in the SCN culture in a dose-de-
pendent fashion, so that GABA might have reduced gap
junction communication between SCN neurons via the
GABAA receptor [14]. In that study they could not clarify
how the activation of a GABAA receptor and subsequent
increase in chloride conductance impact gap junctions. In
studies, it has been reported that increases in intracellular
Ca+2 or decreases in intracellular pH can uncouple cells
[15]. So they suggest that a participation of the GABA re-
ceptors in the regulation of Ca+2 concentration or intrac-
ellular pH could explain the uncoupling effect of
muscimol. As a matter of fact it was suggested that the gap
junction coupling state between neurons in SCN is not
static but dynamically regulated by the GABAA receptor
system [14]. Also in vitro guinea-pig brain preparation
prolonged seizure-like activity elicited using a brief appli-
cation of bicuculline was abolished by the GJ channel
blockers octanol and glycyrrhetinic acid as well as by in-
tracellular acidification [16].
It is suggested that carbenoxolone, by blocking GJ chan-
nels inhibits both the induction and duration of epilepsy
in the in vivo models of seizures. From previous evidences
we speculate that carbenoxolone, by closing GJ channels,
possibly directly or via the GABAergic system, inhibits the
spread of depolarization waves in the CNS and peripheral
organs. These could explain the anticonvulsant, muscle re-
laxant and hypnotic effects of carbenoxolone. But further
experiments need to establish this hypothesis.
At anticonvulsant doses, carbenoxolone produced a hyp-
notic effect in the pentobarbitone sleep test and motor
impairment in the rotarod test, but only at a dose of (400
mg/kg), which had anticonvulsant effect, did carbenox-
olone show muscle relaxant activity in the traction test.
In the potentiation of pentobarbitone sleep test,
carbenoxolone significantly showed sedative effect. Gly-
cyrrhetinic acid is an aglycone saponin extracted from
licorice root [7] and saponines have hypnotic effects [17].
Carbenoxolone is also the succinyl ester of glycyrrhetinic
acid. Thus, this can explain the sedative effect of
carbenoxolone.
In the muscle coordination test, carbenoxolone showed a
muscle relaxant effect. Synchronized firing is a widespread
phenomenon in the mammalian brain [18,19] including
the motor cortex [20], respiratory motor neurons [21,22]
and limb motor neurons [23,24]. These studies have dem-
onstrated the presence of gap junctions in many levels of
the motor system, in both motor neurons and in
premotor pattern generating circuits. Further gap junction
coupling (GJC) has brought about robust coordination
patterns, even in the absence of chemical synapses, and
has been shown to mediate synchronization of neurons
during motor behaviors [25].
On the other hand, as yet there is no information about
the effects of carbenoxolone in the muscle tissues; there-
fore, the possibility exists that these channels may be in
muscles and synchronize the firing between muscle cells.
Carbenoxolone by blocking these channels causes motor
impairment. However, a demonstration of whether these
channels are, in fact, capable of mediating electrical trans-
mission requires physiological experiments.
Thus, we conclude that carbenoxolone has anticonvul-
sant, muscle relaxant and hypnotic effects in the in vivo
models, possibly via blocking GJ channels. The exact
mechanism of these effects needs further investigation.
Materials and Methods
Chemicals
Carbenoxolone, pentylenetetrazole and pentobarbitone
were obtained from Sigma. Diazepam was from Daru Pa-
khsh Pharmaceutical Co., Iran in the form of ampoule (2
mg/10 ml).
All drugs were dissolved in a physiological saline solution.
Animals
Male BALB/c mice, 25–30 g were obtained from the ani-
mal house of Pharmaceutical Research Center, Bu-Ali Re-
search Institute of Mashhad University of Medical
Sciences. The animals were housed in colony rooms with
12/12 h light/dark cycle at 21 ± 2°C and had free access to
food and water.
All animal experiments were carried out in accordance
with Mashhad University of Medical Sciences, Ethical
Committee Acts.BMC Pharmacology 2003, 3 http://www.biomedcentral.com/1471-2210/3/3
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Anticonvulsant activity
Pentylenetetrazole (PTZ) Seizure model
Mice were divided into groups of seven. Diazepam,
carbenoxolone and normal saline were injected intraperi-
toneally (i.p) 30, 60 and 60 min respectively, before the
administration of pentylenetetrazole (i.p, 90 mg/kg). The
onset of a general clonus was used as the endpoint. The
general clonus was characterized by forelimb clonus fol-
lowed by full clonus of the body. The time taken before
the onset of clonic convulsions, the duration of clonic
convulsions, and the percentage of seizure and mortality
protection were recorded [26].
Maximal electroshock seizure (MES) model
Mice were divided into groups of seven. An alternating
current stimulus of 50 Hz and 150 mA through ear-clip
electrodes was delivered for 0.2 sec to the experimental
animals. A drop of 0.9% saline solution was poured into
each ear prior to placing the electrodes. Diazepam,
carbenoxolone and normal saline are injected intraperito-
neally (i.p) 30, 60 and 60 min, respectively before the test.
The duration of tonic convulsion (a tonic extension of the
hindlimb), the percentage of seizure and the mortality
protection were recorded [26].
Potentiation of sodium pentobarbitone sleep
Mice were divided into groups of ten. Carbenoxolone at
doses 100, 200 and 300 mg/kg and diazepam at the dose
of 1 mg/kg and normal saline (10 ml/kg) were injected in-
teraperitonially to separate groups. 1 h after receiving
carbenoxolone and normal saline and 30 min after receiv-
ing diazepam, each animal was injected sodium pento-
barbitone (30 mg/ kg, i.p). The sleeping time was noted
by recording the interval between the loss and regaining
of righting reflex [27].
Muscle relaxant activity
This was examined by: (a) Traction test and (b) Rotarod
test
Traction test
Forepaws of a mouse were placed on a small twisted wire
rigidly supported above a bench top. Normal mice
grasped the wire with forepaws and when allowed to hang
free, placed at least one hind foot on the wire within 5 sec-
onds. Inability to put up at least one hind foot constituted
failure to the traction [28].
The test was conducted in groups of ten previously
screened animals, 1 h after the injection of either saline
(10 ml/kg) or carbenoxolone (200, 300 and 400 mg/kg)
and 30 min after diazepam (0.125, 0.25, 0.5 mg/kg).
Rotarod test
Motor coordination and balance were tested using accel-
erating rotarod (TSE RotaRod System). Mice were placed
on a horizontal metal coated rod with rubber (3 cm diam-
eter) rotating at an initial speed of 10 rpm/min. Terminal
speed of the rod was 20 rpm in accelerated studies and ro-
tational velocity of the rod was linearly increased from 10
to 20 rpm within 20 s. The time each animal was able to
maintain its balance walking on top of the rod was meas-
ured. Mice were given two trials with a maximum time of
300 s and a 30 to 60 min intertrial rest interval. [29]. Be-
fore the beginning of all experiments, the riding ability of
the animals in the rotarod was checked. Thus, the mice
were initially put on a rotating rod, and mice that
immediately dropped off (within 30 s) were removed
from the experiment.
Mice were divided into groups of ten. Diazepam (1 mg/
kg), carbenoxolone (100, 200 and 300 mg/kg) and nor-
mal saline (10 ml/kg) were injected 30, 60 and 60 min-
utes respectively, before the test.
Statistical analysis
The dose of carbenoxolone to produce an anticonvulsant
(ED50) effect in 50% of animals and its associated 95%
confidence limits was calculated by Litchfield and Wilcox-
on methods (PHARM/PCS Version 4). Data were ex-
pressed as mean values ± SEM and tested with variance
analysis followed by the multiple comparison tests to
Tukey-Kramer for the anticonvulsant activity and for the
sleeping activity.
Fischer's exact test (two sided) in traction test and one-
way ANOVA with post hoc comparisons analyzed by
Dunnetts test were used in the accelerod performance.
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